AstraZeneca To Close India R&D Center Studying Neglected Diseases
This article was originally published in PharmAsia News
Executive Summary
AstraZeneca said it would close its research-and-development center in India later this year, which means dropping its early-stage research on neglected tropical diseases such as malaria and tuberculosis.